KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Liabilities and Shareholders Equity (2016 - 2025)

Globus Medical (GMED) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $5.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 0.97% year-over-year to $5.3 billion, compared with a TTM value of $20.1 billion through Dec 2025, down 1.01%, and an annual FY2025 reading of $5.3 billion, up 0.97% over the prior year.
  • Liabilities and Shareholders Equity was $5.3 billion for Q4 2025 at Globus Medical, up from $5.1 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $5.4 billion in Q3 2023 and bottomed at $1.7 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $3.5 billion, with a median of $3.5 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 170.98% in 2023, then decreased 5.04% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $2.0 billion in 2021, then grew by 6.07% to $2.1 billion in 2022, then soared by 144.98% to $5.1 billion in 2023, then grew by 3.26% to $5.3 billion in 2024, then increased by 0.97% to $5.3 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for GMED at $5.3 billion in Q4 2025, $5.1 billion in Q3 2025, and $5.0 billion in Q2 2025.